Palisade Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,700
| Closed | -$206K | – | 452 |
|
|
2017
Q1 | $206K | Sell |
1,700
-1,300
| -43% | -$158K | 0.01% | 416 |
|
|
2016
Q4 | $367K | Buy |
+3,000
| New | +$367K | 0.01% | 424 |
|
|
2015
Q2 | – | Sell |
-2,201
| Closed | -$381K | – | 546 |
|
|
2015
Q1 | $381K | Hold |
2,201
| – | – | 0.01% | 466 |
|
|
2014
Q4 | $407K | Sell |
2,201
-650
| -23% | -$120K | 0.01% | 439 |
|
|
2014
Q3 | $473K | Sell |
2,851
-1,261
| -31% | -$209K | 0.01% | 431 |
|
|
2014
Q2 | $642K | Sell |
4,112
-768
| -16% | -$120K | 0.02% | 401 |
|
|
2014
Q1 | $742K | Sell |
4,880
-2,449
| -33% | -$372K | 0.02% | 380 |
|
|
2013
Q4 | $974K | Sell |
7,329
-2,534
| -26% | -$337K | 0.03% | 339 |
|
|
2013
Q3 | $1.15M | Sell |
9,863
-9,697
| -50% | -$1.13M | 0.03% | 341 |
|
|
2013
Q2 | $1.8M | Buy |
+19,560
| New | +$1.8M | 0.05% | 322 |
|